Study reveals increased restrictions on coverage of buprenorphine for Medicare Part D plans By Dr. Jessica Badichek, PharmD A recent study published in JAMA, the Journal of the American Medical Association, summarized findings on the coverage of buprenorphine under Medicare Part D. Buprenorphine and buprenorphine...
FDA supports development of over-the-counter naloxone By Dr. Jessica Badichek, PharmD A recent statement from FDA Commissioner Dr. Scott Gottlieb summarized the FDA’s new efforts in encouraging drug manufacturers to develop an over-the-counter version of naloxone, the opioid overdose treatment. The FDA stated that...
Drug Overdoses linked to Synthetic Opioids By Dr. Jessica Badichek, PharmD According to CDC analysis of the latest drug overdose death data, there were 63,632 drug overdose deaths in the United States in 2016. This was calculated as a 21.4% increase from 2015 data...
Addiction Treatment & Telemedicine: An Update By Dr. Jessica Badichek, PharmD The Centers for Medicare and Medicaid Services (CMS) recently published a report summarizing current evidence and practices in telemedicine-based services. This report discusses the substance abuse treatment barriers that persist throughout the country...
This website may use cookies to improve your experience. You can opt-out if you wish. Cookie settingsACCEPT
Cookies Policy
Privacy Overview
This website may use cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We may also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.